Literature DB >> 22106910

The spectrum of ocular involvement in systemic lupus erythematosus in a tertiary eye care center in Nepal.

Ranju Sitaula1, Dev Narayan Shah, Divya Singh.   

Abstract

PURPOSE: Manifestations of Systemic lupus erythematosus are protean and the eye can get affected in more than a third of the cases. This study was conducted to evaluate the spectrum of ocular manifestation among Nepalese patients diagnosed with Systemic lupus erythematosus.
METHODS: In this hospital based cross-sectional study, 91 established cases of Systemic lupus erythematosus were enrolled from January 2008 to June 2009 AD. Patient particulars including age, sex, duration, systemic involvement, laboratory findings and treatment history were noted. Detailed ophthalmological examination was carried.
RESULTS: Out of 91 patients, 94.5% were females and 5.5% were males. Female/Male ratio was 17:1. Mean age of the patients was 26.59 ± 10.33 years. Ocular involvement was present in 47.3% (43) of the patients, the commonest manifestation being dry eye (39.5%) followed by lupus retinopathy (21%) and drug induced ocular complications (21%).
CONCLUSIONS: Ocular manifestations in Systemic lupus erythematosus are not uncommon.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22106910     DOI: 10.3109/09273948.2011.610023

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  8 in total

1.  Risk factors for cataracts in systemic lupus erythematosus (SLE).

Authors:  Khaled Alderaan; Vuk Sekicki; Laurence S Magder; Michelle Petri
Journal:  Rheumatol Int       Date:  2014-09-26       Impact factor: 2.631

Review 2.  Gender disparities in ocular inflammatory disorders.

Authors:  Hatice Nida Sen; Janet Davis; Didar Ucar; Austin Fox; Chi Chao Chan; Debra A Goldstein
Journal:  Curr Eye Res       Date:  2014-07-02       Impact factor: 2.424

3.  Macular and peripapillary vessel density alterations in a large series of patients with systemic lupus erythematosus without ocular involvement.

Authors:  Sevgi Subasi; Kubra Demirci Kucuk; Senar San; Ayse Cefle; Ecem Onder Tokuc; Sibel Balci; Ayten Yazici
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-06       Impact factor: 3.535

4.  Ocular manifestations of systemic lupus erythematosus: a review of the literature.

Authors:  Neal V Palejwala; Harpreet S Walia; Steven Yeh
Journal:  Autoimmune Dis       Date:  2012-07-02

5.  Increased utilisation of eye disorder-related ambulatory medical services prior to the diagnosis of Sjögren's syndrome in female patients: a longitudinal population-based study in Taiwan.

Authors:  Ming-Chi Lu; Wen-Hsiung Fa; Tzung-Yi Tsai; Malcolm Koo; Ning-Sheng Lai
Journal:  BMJ Open       Date:  2014-05-20       Impact factor: 2.692

6.  Dry Eye Indexes Estimated by Keratograph 5M of Systemic Lupus Erythematosus Patients without Secondary Sjögren's Syndrome Correlate with Lupus Activity.

Authors:  An Wang; Zhengyu Gu; Rongfeng Liao; Zongwen Shuai
Journal:  J Ophthalmol       Date:  2019-08-29       Impact factor: 1.909

7.  Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy.

Authors:  Ruchi Shrestha; Ranju Kharel Sitaula; Pratap Karki; Sagun Narayan Joshi; Suniti Rawal
Journal:  Int Med Case Rep J       Date:  2019-10-30

8.  Prevalence and Spectrum of Eye Disorders Among Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus in a Tertiary Hospital in Northern Nigeria.

Authors:  Maryam H Abdullahi; Victoria Pam; Kehinde Kabir Oladigbolu; Abdul Aziz Umar; Rilwan Chiroma Muhammad
Journal:  J West Afr Coll Surg       Date:  2022-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.